5Shaarawy M. Didy HE. Thrombomodulin ,plasinogen activator inhibitor type-1 and fibornectin as biommarkers of endothelial damage in preeclampsia and eclampsia, Int Gynecol Obstet, 1996, 55(1):135-139.
6Woo KS,Chook P,Lolin YI,et al. Hypehomocysteinemia is a risk factors for arterial endothelial dysfunction in humans. Circulation,1997,96(8) : 2542-2544.
52 Stamler JS, Osborne JA, Jaraki O,et al. Adverse vascular effects homocysteine aremodulated by endothelium-derived relaxing factor and related oxides of nitrogen. J ClinInvest,1993,91:308-318.
63 Sohda S, Arinami T, Hamada H,et al. Methylenetetrahydrofolate reductasepoly-morphism and preeclampsia.J Med Genet,1997,34:525-526.
74 McCully KS. Homocysteine and vascular disease.Nat Med,1996,2:386-389.
85 Constantine G,Green A. Untreated homocystinuria: a maternal death in a women with fourpregnancies.Case report. Br J Obstet Gynaecol,1987,94:803-806.
96 Steegers-Theunissen RP,Boers GH,Blom HJ,et al. Hyperhomocysteinaemia and recurrentspontaneous abortion or abruptio placentae.Lancet,1992,339:1122-1123.
